Medicine and Dentistry
Patient
100%
Placenta Accreta
61%
Ovarian Cancer
53%
Bevacizumab
33%
Hysterectomy
30%
Oncologist
30%
Endometrial Cancer
27%
Woman
24%
Therapeutic Procedure
21%
Counseling
21%
Neoplasm
21%
Surgery
20%
Diseases
20%
Malignant Neoplasm
19%
Cancer Cell
19%
Combination Therapy
17%
Weight Loss
15%
Vagina Bleeding
15%
Specimen
14%
Inpatient
14%
Paclitaxel
14%
Progression Free Survival
14%
Recurrent Disease
14%
Pelvis
13%
Uterine Artery Embolization
13%
Cervix
13%
Transfusion
13%
Cervical Cancer
13%
Programmed Cell Death
12%
Maternal Morbidity
12%
Krukenberg Tumor
12%
Piperidone Derivative
12%
Crush Trauma
12%
Fertility
12%
Surgical Margin
12%
Injury
12%
Sentinel Lymph Node Biopsy
12%
Lymphedema
12%
Uterine Cervix Conization
12%
Soft Tissue
12%
Familial Cancer
12%
Tranexamic Acid
12%
Blood Transfusion
12%
Cells
11%
Overall Survival
11%
Pregnancy
10%
Gynecological Oncology
10%
BRCA1
10%
Athletic Training
9%
Incidence
9%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
41%
Piperidone Derivative
17%
Triple Negative Breast Cancer
12%
Neoplasm
11%
Malignant Neoplasm
11%
Diseases
11%
Bevacizumab
10%
Recurrent Disease
9%
Pembrolizumab
9%
Niraparib
9%
Progression Free Survival
8%
Curcumin
8%
Cytotoxicity
6%
Nursing and Health Professions
Bevacizumab
13%
Hysterectomy
13%
Transfusion
12%
Blood Transfusion
12%
Placenta Accreta
12%
Patient
12%
Drill
12%
Time
8%
Progression Free Survival
7%
Robotics
7%
Inpatient
5%
